News

SingleCare analyzed consumer prescription demand and fill data in the weeks leading up to shelter in place orders, beginning in March, and the subsequent months after the pandemic to see how COVID has impacted the healthcare trends of Americans.

Guidelines to prevent retinopathy caused by a drug to treat autoimmune disease must be developed jointly by ophthalmologists and prescribing physicians, journal authors say.

How real-world evidence will help FDA develop a vaccine.

Heart disease drugs were in the news this week.

Patients with major depressive disorder have higher healthcare utilization rates when they experience certain key clinical events, according to a new study.

Although the importance of comprehensive records management programs is not a new phenomenon, over the last few months events surrounding COVID-19 have brought records management into increased focus.

A minority camp of MS researchers argue that the disease may begin within pathologically processes within the central nervous system.

Study published in Annals of Neurology shows about half of RIS patients have a clinical event that typifies MS within 10 years.

More research is needed on how MS affects women throughout the life span.

In this week's episode of Tuning Into the C-Suite podcast, Briana Contreras of MHE speaks with Ben Kanter, MD, board-certified pulmonologist and chief medical information officer for Vocera Communications, not only about how critical it is for hospitals to have sufficient supplies of non-contaminated PPE for the safety of patients and healthcare workers, but also to discuss solutions of technology, collaboration and more that address the challenges of delivering patient care while wearing PPE.

When universal testing was implemented, 40% of the tested residents were positive for SARS-CoV-2.

CDC issued a newly updated mask consideration which includes alternatives and adaptations for those with hearing loss and other communication disorders.

The Network’s Board of Trustees has appointed Mansue as the new president and CEO, effective September 1. She will succeed John DiAngelo, who announced his intention to retire in January following his 20-year tenure with the organization.

The pharma maker is partnering with the nonprofit Civica Rx to help reduce shortages in hospitals.

The fast-evolving field of precision medicine offers the promise of more effective treatments and better outcomes, and it’s time that we collaborate to keep outdated clinical and reimbursement practices from slowing it down.

Families USA estimates that 1 in 7 adult Americans don't have health insurance.

Are patients with MS taking DMTs at higher risk of infection or case severity during COVID-19? A small study suggests that may not the case with one.

The higher case-fatality rate could be because of low resting rates, a greater number of deaths, or both,

Five other manufacturers have recalled the popular diabetes medication due to the presence of a the carcinogenic ingredient.

From staffing to readmissions to diagnostics, data intelligence is poised to revolutionize healthcare.

Patients with diabetic macular edema whose vision remains impaired even with the best available treatments may soon have a combination therapy.

Jim Beiermann, CFO, and Danny Irland, senior vice president of network operations and chief network officer of Southwestern Health Resources discuss their focus of value-based care through ACO and Next Generation Programs within the company with Managed Healthcare Executive Senior Editor, Peter Wehrwein.

Study of program in Oregon suggests that fee-for-service may be the reason for the underwhelming results for patient-centered medical homes.

Federal agency is dispatching Quality Improvement Organizations to hotspots.

The healthcare tech company will assist health plans in meeting Care for Older Adults requirements.

Jim Beiermann and Danny Irland, both of Southwestern Health Resources, discuss their focus of value-based care through ACO and Next Generation Programs.

Peter Wehrwein, senior editor at Managed Healthcare Executive, spoke with Lisa Griffin, senior vice president of front-end operations at Jefferson Health in Philadelphia, about the pivot to telehealth, "seamless access" and racism.

Vote in May made FDA-approved biosimilars an "appropriate substitution" for brand-name biologics in NCCN guidelines.